share_log

Illumina | DEF 14A: Definitive information statements

Illumina | DEF 14A: Definitive information statements

Illumina | DEF 14A：股东委托书决议
SEC announcement ·  04/04 16:22
Moomoo AI 已提取核心信息
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced the filing of its definitive proxy statement with the SEC, scheduling its annual meeting of stockholders for May 16, 2024. The meeting, to be held virtually, will allow stockholders to elect eleven board nominees, ratify the appointment of Ernst & Young LLP as the independent auditor for the fiscal year ending December 29, 2024, and vote on an advisory resolution to approve executive compensation. The Board unanimously recommends voting for all proposals. Stockholders as of the record date, March 22, 2024, are entitled to vote. The proxy materials are available at www.proxyvote.com, and stockholders can vote via the internet, telephone, or mail prior to the meeting. The Board also addressed the anticipated divestiture of GRAIL, aiming to finalize terms by the second quarter of 2024. The proxy statement includes compensation details for named executive officers, with CEO Jacob Thaysen's compensation package reflecting stockholder feedback on performance alignment.
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced the filing of its definitive proxy statement with the SEC, scheduling its annual meeting of stockholders for May 16, 2024. The meeting, to be held virtually, will allow stockholders to elect eleven board nominees, ratify the appointment of Ernst & Young LLP as the independent auditor for the fiscal year ending December 29, 2024, and vote on an advisory resolution to approve executive compensation. The Board unanimously recommends voting for all proposals. Stockholders as of the record date, March 22, 2024, are entitled to vote. The proxy materials are available at www.proxyvote.com, and stockholders can vote via the internet, telephone, or mail prior to the meeting. The Board also addressed the anticipated divestiture of GRAIL, aiming to finalize terms by the second quarter of 2024. The proxy statement includes compensation details for named executive officers, with CEO Jacob Thaysen's compensation package reflecting stockholder feedback on performance alignment.
DNA测序和基于阵列的技术领域的全球领导者Illumina, Inc. 宣布向美国证券交易委员会提交其最终委托书，并计划于2024年5月16日举行年度股东大会。该会议将以虚拟方式举行，将允许股东选出11名董事会候选人，批准任命安永会计师事务所为截至2024年12月29日的财政年度的独立审计师，并对批准高管薪酬的咨询决议进行投票。董事会一致建议对所有提案进行投票。截至创纪录的日期，即2024年3月22日，股东有权投票。代理材料可在www.proxyvote.com上获得，股东可以在会议之前通过互联网、电话或邮件进行投票。董事会还讨论了GRAIL的预期剥离，目标是在2024年第二季度之前敲定条款。委托书包括指定执行官的薪酬细节，首席执行官雅各布·塞森的薪酬待遇反映了股东对业绩调整的反馈。
DNA测序和基于阵列的技术领域的全球领导者Illumina, Inc. 宣布向美国证券交易委员会提交其最终委托书，并计划于2024年5月16日举行年度股东大会。该会议将以虚拟方式举行，将允许股东选出11名董事会候选人，批准任命安永会计师事务所为截至2024年12月29日的财政年度的独立审计师，并对批准高管薪酬的咨询决议进行投票。董事会一致建议对所有提案进行投票。截至创纪录的日期，即2024年3月22日，股东有权投票。代理材料可在www.proxyvote.com上获得，股东可以在会议之前通过互联网、电话或邮件进行投票。董事会还讨论了GRAIL的预期剥离，目标是在2024年第二季度之前敲定条款。委托书包括指定执行官的薪酬细节，首席执行官雅各布·塞森的薪酬待遇反映了股东对业绩调整的反馈。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息